Cleary Gottlieb acted as counsel to the underwriters in Sanofi’s registered offering of an aggregate principal amount of $2 billion of debt securities, including $1 billion of 3.375 percent notes due 2023, and $1 billion of 3.625 percent notes due 2028.
This offering priced on June 12, 2018, and closed on June 19, 2018. Barclays and Morgan Stanley acted as global coordinators and joint book-running managers and Citigroup, Deutsche Bank, and MUFG acted as joint book-running managers for the offering.
Sanofi intends to use the proceeds of the bond offering for general corporate purposes including the repayment of existing borrowings.
Sanofi is a leading global healthcare company, focused on patient needs and engaged in the research, development, manufacture and marketing of therapeutic solutions. Sanofi is the fifth largest pharmaceutical group in the world and the third-largest in Europe in terms of sales.